InvestorsHub Logo
Followers 85
Posts 6169
Boards Moderated 0
Alias Born 05/27/2009

Re: Nebuchadnezzar post# 96

Wednesday, 09/29/2021 8:08:51 AM

Wednesday, September 29, 2021 8:08:51 AM

Post# of 182
Watch for results of GRAY speaking at Cantor Fitzgerald Global Healthcare Conference 9/28.
Imagine the Big Pharma eyes & interest for GRAY's confirmed results 9/28 for "full-data analysis from the 18-month Phase 2b ALTISSIMO trial of GB-102 for the treatment of wet age-related macular degeneration (wet AMD)" along with GRAY's $78.2m on hand at this conference. Big Pharma interest for sure...

Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of diseases of the retina and optic nerve, today announced that Fred Guerard, PharmD, Chief Executive Officer of Graybug Vision, will present at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 11:20 a.m. ET / 8:20 a.m. PT. Dr. Guerard will provide a corporate update, including a full analysis of the 18-month data from the ALTISSIMO Phase 2b trial of GB-102 1mg.

A live webcast of the presentation will be available in the Investors and Media section of the company's website at https://investors.graybug.vision/news-events/events-presentations, with a replay available shortly after the live event.

GLTA
...
.....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GRAY News